Peter Lamb
Corporate Officer/Principal at EXELIXIS, INC.
Net worth: 10 M $ as of 31/03/2024
Profile
Peter Lamb occupies the position of Chief Scientific Officer & EVP-Scientific Strategy at Exelixis, Inc. Dr. Lamb previously was Director-Transcription Research at Ligand Pharmaceuticals, Inc. He received a doctorate from the University of London and an undergraduate degree from the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC.
0.14% | 15/12/2022 | 428,063 ( 0.14% ) | 10 M $ | 31/03/2024 |
Peter Lamb active positions
| Companies | Position | Start |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 15/12/2022 |
Former positions of Peter Lamb
| Companies | Position | End |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/09/2000 |
Training of Peter Lamb
| University of Cambridge | Undergraduate Degree |
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| EXELIXIS, INC. | Health Technology |
- Stock Market
- Insiders
- Peter Lamb
